Bristol-Myers Squibb Company To Pay $300 Million In Settlement

Drug giant Bristol-Myers Squibb Co. said Friday it will pay $300 million to settle a class-action lawsuit that accused the company of lying about accounting and its investment in ImClone Systems Inc.
MORE ON THIS TOPIC